SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-217482
Filing Date
2021-07-16
Accepted
2021-07-16 16:43:21
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 d143204d424b4.htm 424B4 1907254
2 GRAPHIC g143204g02q83.jpg GRAPHIC 158774
3 GRAPHIC g143204g03q84.jpg GRAPHIC 130023
4 GRAPHIC g143204g04q55.jpg GRAPHIC 98739
5 GRAPHIC g143204g04q85.jpg GRAPHIC 120633
6 GRAPHIC g143204g05q55.jpg GRAPHIC 39432
7 GRAPHIC g143204g06s25.jpg GRAPHIC 44692
8 GRAPHIC g143204g10q55.jpg GRAPHIC 123028
9 GRAPHIC g143204g11i13.jpg GRAPHIC 106039
10 GRAPHIC g143204g11q55.jpg GRAPHIC 129270
11 GRAPHIC g143204g12s64.jpg GRAPHIC 61530
12 GRAPHIC g143204g15x33.jpg GRAPHIC 76734
13 GRAPHIC g143204g47e89.jpg GRAPHIC 112152
14 GRAPHIC g143204g84m65.jpg GRAPHIC 130526
15 GRAPHIC g143204g85i23.jpg GRAPHIC 48303
16 GRAPHIC g143204g96x04.jpg GRAPHIC 263090
  Complete submission text file 0001193125-21-217482.txt   4170180
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080 650 325 5156
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1214
Type: 424B4 | Act: 33 | File No.: 333-257419 | Film No.: 211095904
SIC: 2834 Pharmaceutical Preparations